The global neuroendocrine carcinoma treatment market was valued US$ 1.7 Bn in 2022, and is expected to exhibit a CAGR of 8% during the forecast period (2022 – 2029).Prominently driven by collaborative strategies for speedy research of drugs for neuroendocrine carcinoma treatment, the market is set for an impressive.
NEW YORK, June 16, 2022 /PRNewswire/ As per Zion Market Research study, The global oral proteins and peptides market registered a revenue growth of around USD 1.24 billion in 2021 and is